Search Results 41-50 of 1116 for B cell lymphomas
Some lymphomas grow very slowly, and it may not be necessary to start treatment right away.
The FDA has approved CAR -T cell therapy for relapsed, refractory (RR) B-cell lymphoma, mantle cell lymphoma, follicular lymphoma, multiple myeloma ...
A Study to Evaluate the Safety and Effectiveness of ALLO-501A CAR T Cell Therapy in Adults with Relapsed/ Refractory Large B Cell Lymphoma Scottsdale/Phoenix, Ariz.
The FDA-approved conditions for CAR -T cell therapy include: B-cell precursor acute lymphoblastic leukemia (ALL), in people up to 25 years of age Diffuse large B-cell lymphoma (DLBCL...
In stem cell transplants, stem cells replace cells damaged by chemotherapy or disease or serve as a way for the donor's immune system to fight some types of cancer and blood-related diseases, such as...
Subtypes of non-Hodgkin's lymphoma that involve T cells include peripheral T-cell lymphoma and cutaneous T-cell lymphoma.
Giving paclitaxel albumin-stabilized nanoparticle formulation and rituximab may work better in treating patients with B-cell non-Hodgkin lymphoma.
CAR -T cell therapy may be a treatment option for: Relapsed, refractory B-cell acute lymphoblastic leukemia Relapsed, refractory B-cell non-Hodgkin's lymphoma Relapsed, refractory ma...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma.
Blood and Marrow Stem Cell Transplantation Clinic in Minnesota Overview Blood and Bone Marrow Transplantation Dermatology Clinic Watch Mayo Clinic dermatologist Julia Lehman, M.D., describe how specialists work together to help peopl...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.